Abstract:Abstractβ-Alanine is a naturally occurring β-amino acid that has been widely applied in the life and health field. Although microbial fermentation is a promising method for industrial production of β-alanine, an efficient microbial cell factory is still lacking. In this study, a new metabolically engineered Escherichia coli strain for β-alanine production was developed through a series of introduction, deletion, and overexpression of genes involved in its biosynthesis pathway. First, the L-aspartate a-decarboxylase gene, BtADC, from Bacillus tequilensis, with higher catalytic activity to produce β-alanine from aspartate, was constitutively expressed in E. coli, leading to an increased production of β-alanine up to 2.76 g/L. Second, three native aspartate kinase genes, akI, akII, and akIII, were knocked out to promote the production of β-alanine to a higher concentration of 4.43 g/L by preventing from bypass loss of aspartate. To increase the amount of aspartate, the native AspC gene was replaced with PaeAspDH, a L-aspartate dehydrogenase gene from Pseudomonas aeruginosa, accompanied with the overexpression of the native AspA gene, to further improve the production level of β-alanine to 9.27 g/L. Last, increased biosynthesis of oxaloacetic acid (OAA) was achieved by a combination of overexpression of the native PPC, introduction of CgPC, a pyruvate decarboxylase from Corynebacterium glutamicum, and deletion of ldhA, pflB, pta, and adhE in E. coli, to further enhance the production of β-alanine. Finally, the engineered E. coli strain produced 43.12 g/L β-alanine in fed-batch fermentation. Our study will lay a solid foundation for the promising application of β-alanine in the life and health field.Key Points• Overexpression of BtADC resulted in substantial accumulation of β-alanine.• The native AspC was replaced with PaeAspDH to catalyze the transamination of OAA.• Deletion of gluDH prevented from losing carbon flux in TCA recycle.• A 43.12-g/L β-alanine production in fed-batch fermentation was achieved.Graphical abstract

Study on the construction technology of β-alanine synthesizing Escherichia coli based on cellulosome assembly

Pathway construction and metabolic engineering for fermentative production of β-alanine in Escherichia coli

Multiplex modification of Escherichia coli for enhanced β-alanine biosynthesis through metabolic engineering

Re-designing Escherichia coli for high-yield production of β-alanine by metabolic engineering

Rerouting Fluxes of the Central Carbon Metabolism and Relieving Mechanism-Based Inactivation of l -Aspartate-α-decarboxylase for Fermentative Production of β-Alanine in Escherichia coli

Efficient Fermentative Production of Β-Alanine from Glucose Through Multidimensional Engineering of Escherichia Coli.

Enhancement of β-Alanine Biosynthesis in Escherichia coli Based on Multivariate Modular Metabolic Engineering

Systems engineering of Escherichia coli for high-level l-alanine production

Metabolic engineering of E. coli for β-alanine production using a multi-biosensor enabled approach

Development of probiotic E. coli Nissle 1917 for β-alanine production by using protein and metabolic engineering

High-yield β-alanine production from glucose and acetate in Escherichia coli

Improving the Synthesis Efficiency of Amino Acids Such as L-Lysine by Assembling Artificial Cellulosome Elements Dockerin Protein In Vivo

Enhanced production of β-alanine through co-expressing two different subtypes of L-aspartate-α-decarboxylase

Extracellular Expression of L-Aspartate-α-Decarboxylase from Bacillus tequilensis and Its Application in the Biosynthesis of β-Alanine

Efficient biosynthesis of D/L-alanine in the recombinant Escherichia coli BL21(DE3) by biobrick approach

Metabolic Engineering of Bacillus megaterium for the Production of β-alanine

Metabolic engineering of Corynebacterium glutamicum for producing branched chain amino acids

Engineered production of 5-aminolevulinic acid in recombinant Escherichia coli BL21

Efficient biosynthesis of 5-aminolevulinic acid from glutamate via whole-cell biocatalyst in immobilized engineered Escherichia coli

L-Cysteine Production In Escherichia Coli Based On Rational Metabolic Engineering And Modular Strategy

Systems engineering of Escherichia coli for high-level glutarate production from glucose